Top Markets
Coin of the day
Imagion Biosystems Limited Imagion Biosystems Limited

Imagion Biosystems Limited

IBX
Classifica tra le azioni #35262
Imagion Biosystems Limited operates as a medical imaging company that uses... Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Prezzo delle azioni
$0.00775813
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$4.19M
Variazione (1 giorno)
-15.38%
Variazione (1 anno)
-20.49%
Paese
AU
Scambia Imagion Biosystems Limited (IBX)

Categoria

Storico del rendimento da dividendi per Imagion Biosystems Limited (IBX)
Il rendimento da dividendi (TTM) di Imagion Biosystems Limited (simbolo azionario: IBX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Imagion Biosystems Limited (IBX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti